MIRA INFORM REPORT

 

IDENTIFICATION DETAILS

 

Name :

SENTISS PHARMA PRIVATE LIMITED (w.e.f. 06.06.2013)

 

 

Formerly Known As :

PROMED EXPORTS PRIVATE LIMITED

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

PAN No.:

[Permanent Account No.]

AAACP1612Q

 

 

Legal Form :

Private Limited Liability Company

 

 

No. of Employees :

Not Available

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals Products

 

 

Exports :

 

Countries :

·         Russia

·         US

·         UK

 

 

Imports :

 

Products :

API Pharma Ingredient

Countries :

China

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         Citibank N.A, Jeevan Bharti Building, 4th Floor, 124, Connaught Circus, Connaught Place, New Delhi - 110001, Delhi, India

·         ICICI Bank Limited Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India

·         Standard Chartered Bank, Credit Documentation Unit, Narain Manzil, 23 Barakhamba Road, New Delhi - 110001, India

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Foreign currency term loans from banks

47.386

80.640

Rupee term loans from others

28.300

38.350

SHORT TERM BORROWINGS

 

 

 

 

 

Working capital loans from banks

59.019

0.000

Total

134.705

118.990

 

Banking Relations :

--

 

 

Financial Instituation :

3i Infotech Trusteeship Services Limited, 3 to 6th Floor, Internationla Infotech Park, Tower No. 5, Vashi Railway Station Complex, Vashi, Navi Mumbai – 400703, Maharashtra, India

 

 

Auditors :

 

Name :

S.R. Batliboi and Company

Chartered Accountants

PAN No. :

AALFS0506L

 

 

Subsidiaries :

Ř       P.E. Promed Europe Limited, Cyprus

 

 

Associate :

Ř       Sidvim LifeSciences Private limited, India

CIN No.: U74990MH2009PTC196378

 

Ř       Pulse Pharma Private Limited, India

CIN No.: U74899DL1995PTC064858

 

 

Fellow Subsidiary company :

Ř       LLC Sentiss Russ, Russian Federation

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 13.09.2013

 

Names of Shareholders

No. of Shares

Rama Kant Sharma

50110

Madhuri Lamba

55

Jyoti Bahri Jointly With Deepak Bahri

1925000

Deepak Bahri Jointly With Jyoti Bahri

3025055

Sidvim Lifesciences Private Limited, India

50000

 

 

Total

5050220

 

As on 13.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Bodies corporate

1.00

Directors or relatives of Directors

98.00

Other top fifty shareholders

1.00

Total

100.00

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

50.502

50.502

50.502

(b) Reserves & Surplus

2081.637

1596.565

1096.730

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2132.139

1647.067

1147.232

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

75.686

118.990

142.459

(b) Deferred tax liabilities (Net)

147.152

119.902

113.262

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.528

2.578

3.126

Total Non-current Liabilities (3)

223.366

241.470

258.847

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

59.019

0.000

50.231

(b) Trade payables

171.084

204.055

151.152

(c) Other current liabilities

73.361

74.364

120.875

(d) Short-term provisions

145.384

151.618

90.452

Total Current Liabilities (4)

448.848

430.037

412.710

 

 

 

 

TOTAL

2804.353

2318.574

1818.789

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

781.396

781.941

786.111

(ii) Intangible Assets

26.277

18.894

23.774

(iii) Capital work-in-progress

1.704

0.134

4.435

(iv) Intangible assets under development

221.684

178.376

131.399

(b) Non-current Investments

47.579

2.658

0.180

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

354.246

291.022

165.187

(e) Other Non-current assets

10.062

9.263

0.000

Total Non-Current Assets

1442.948

1282.288

1111.086

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

322.571

159.994

15.060

(b) Inventories

121.299

103.797

83.960

(c) Trade receivables

730.073

553.965

492.302

(d) Cash and cash equivalents

135.686

185.220

71.141

(e) Short-term loans and advances

51.776

33.310

37.272

(f) Other current assets

0.000

0.000

7.968

Total Current Assets

1361.405

1036.286

707.703

 

 

 

 

TOTAL

2804.353

2318.574

1818.789

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

 

SALES

 

 

 

 

 

Income

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

2412.327

2034.773

1468.997

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

1578.179

1290.975

952.980

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

834.148

743.798

516.017

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

24.493

34.408

21.103

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

809.655

70.939

494.914

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

92.946

81.993

57.629

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                 (G)           

716.709

627.397

437.285

 

 

 

 

 

Less

TAX                                                                  (H)

113.467

10.173

37.070

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

603.242

617.224

400.215

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

100.565

50.730

29.017

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

450.000

450.000

320.000

 

 

Dividend

101.004

101.004

50.502

 

 

Tax on Dividend

17.165

16.385

8.000

 

BALANCE CARRIED TO THE B/S

135.638

100.565

50.730

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

F.O.B. Value of Export

2236.656

1802.129

1347.154

 

TOTAL EARNINGS

2236.656

1802.129

1347.154

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

45.934

26.874

37.353

 

 

Packing Material

22.011

19.187

7.740

 

 

Stores & Spares

14.725

9.275

4.541

 

 

Capital Item

12.096

14.925

52.849

 

TOTAL IMPORTS

94.766

70.261

102.483

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

119.45

122.22

79.25

 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list

 

LOCATIONS

 

Registered Office :

212, Ashirwad Commercial Complex, D-I, Green Park, New Delhi – 110016, India

Tel. No. :

91-11-26863503

Fax No. :

91-11-2698517

E-Mail :

mgarg@promedgroup.com

Website :

www.sentisspharma.com

 

 

Corporate Office :

3rd Floor, 261, Udyog Vihar Phase- IV, Gurgaon - 122001, Haryana, India 

Tel. No. :

91-124-4951100

Fax No. :

91-124-4301263

E-Mail :

information@sentisspharma.com

 

 

Factory :

Village Khera Nihla, Tehsil Nalagarh District Solan – 174101, Himachal Pradesh, India

 

 

Sentiss Research Centre :

261, Udyog Vihar Phase- IV, Gurgaon -122001, Haryana, India

Tel. No. :

91-124-4301264 / 64 / 65

Fax No. :

91-124-4301263

 

 

Provis – a division of Sentiss :

512, 2nd Floor, Udyog Vihar, Phase V, Gurgaon - 122016, Haryana, India

Tel. No. :

91-124-6456069-70

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.